DermTech Announces Topline Results of its TRUST Study: Results Confirm the High Negative Predictive Value of the PLA at 99% and Find No Significant Adverse Outcomes After Long-Term Follow-Up of PLA Negative Tests

DermTech Announces Topline Results of its TRUST Study: Results Confirm the High Negative Predictive Value of the PLA at 99% and Find No Significant Adverse Outcomes After Long-Term Follow-Up of PLA Negative Tests

LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the topline results from its TRUST Study of the company’s non-invasive melanoma rule-out test, the Pigmented Lesion Assay (the “PLA”). The TRUST study is a long-term follow-up study of pigmented skin lesions that tested negative for melanoma with the PLA. It was designed to assess long-term outcomes of PLA negative tests and to further confirm the 99% negative predictive value (“NPV”) of the PLA. Specifically, the study protocol called for reevaluating and retesting lesions that were PLA negative 12 to 24 months prior to each subject’s enrollment in the TRUST Study in order to determine the proportion of true negative lesions among those that tested negative. The PLA enhances early melanoma detection by assessing atypical pigmented lesions (lesions suspicious for melanoma) to help rule out melanoma and the need for surgical evaluation. The PLA detects LINC 518 (long intergenic non-protein coding RNA 518) and PRAME (preferentially expressed antigen in melanoma) as a 2-panel gene expression assay.

The TRUST Study was conducted at five geographically distinct clinical sites in the U.S. that consistently use the PLA to help manage atypical pigmented lesions in their clinical practice. A long-term follow-up cohort of 1,781 lesions with PLA negative tests in a 12 to 24 month period prior to the study’s start were identified and the subjects with such lesions were solicited to return for repeat PLA testing on the same lesion. A total of 302 lesions were evaluated by means of repeat testing with the PLA, meeting the study protocol’s pre-specified enrollment target.

After the enrollment of subjects in the repeat testing arm of the TRUST Study, the NPV and patient outcomes for the full cohort of eligible lesions was established via a prospectively planned chart review for any melanoma diagnoses on the PLA tested lesion, late-stage melanoma diagnoses, and melanoma mortality. Of the 1,781 lesions in the long-term follow-up cohort, there were no melanoma deaths or late-stage melanoma diagnoses reported in the full cohort. Ten lesions from the full cohort had received a melanoma diagnosis after initial testing, with four at Stage 0 (in situ) and six at Stage 1a. A subset of the full cohort, representing 1,233 lesions, had confirmed follow-up evaluations from the initial PLA negative test, and from these evaluations we calculate an NPV of 99.2% (CI95%= 98.5 – 99.6).

Of the 302 lesions evaluated by means of repeat testing with the PLA, none (0%) were found to have clinically obvious melanoma upon the subject’s return to the clinic, confirming the results of the initial chart review. Eighty-nine percent of these lesions (268 lesions) were negative on repeat testing with the PLA and 34 (11.2%) were positive. Positive lesions were biopsied and subjected to a single read histopathologic review. Three lesions (1%) that tested positive on repeat testing were diagnosed as Stage 0, in situ. Photographic review of the three Stage 0 cases identified changes in clinical appearance since the initial test. The pathology reports from the remaining biopsied lesions indicated a variety of non-melanoma diagnoses, including compound nevi with mild to moderate atypia. Given the early stage (in situ) of the melanomas detected on repeat testing, and length of time from the initial test (an average of 15 months), it is difficult to determine whether these melanomas evolved after the initial test or were present at the time of the initial test. In any case, the finding of three melanomas in a cohort of 302 lesions subjected to repeat testing further confirms an NPV of the PLA of at least 99.0% (CI95%= 97.1 – 99.8) and is consistent with the results from the full long-term follow‑up cohort. These results exemplify how PLA repeat testing of lesions that may have evolved over time after the initial negative PLA test, can identify early-stage melanoma and benefit patients.

“These results further support the PLA’s high negative predictive value in routine‑use scenarios and the test’s ability to enhance early melanoma detection. Clinicians should have confidence in the PLA as the long‑term follow-up of PLA negative tests observed in the TRUST Study did not reveal any adverse outcomes,” stated Dr. Burkhard Jansen, DermTech’s CMO.

“The TRUST Study illustrates that the PLA can identify melanoma at the earliest stages to maximize patient benefit,” commented Dr. Maral Skelsey, Director of the Mohs Surgery Unit and Clinical Associate Professor of Dermatology at Georgetown University and one of the TRUST study investigators.

About DermTech

DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by our non-invasive skin genomics platform. DermTech’s mission is to transform the practice of dermatology through more accurate diagnosis and treatment, and the elimination of unnecessary surgery, leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory diseases and customize drug treatments. For additional information on DermTech, please visit DermTech’s investor relations site at: www.DermTech.com.

Forward-looking Statements

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of DermTech may differ from its actual results and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, expectations with respect to: the performance, patient benefits, cost-effectiveness, commercialization and adoption of DermTech’s products, including the Smart Sticker platform, and the market opportunity therefor. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside of the control of DermTech and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the outcome of any legal proceedings that may be instituted against DermTech; (2) DermTech’s ability to obtain additional funding to develop and market its products; (3) the existence of favorable or unfavorable clinical guidelines for DermTech’s tests; (4) the reimbursement of DermTech’s tests by Medicare and private payors; (5) the ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for DermTech’s products; (6) DermTech’s ability to grow, manage growth and retain its key employees; (7) changes in applicable laws or regulations; (8) the market adoption and demand for DermTech’s products and services together with the possibility that DermTech may be adversely affected by other economic, business, and/or competitive factors; and (9) other risks and uncertainties included in (x) the “Risk Factors” section of the most recent Quarterly Report on Form 10-Q filed by DermTech with the Securities and Exchange Commission (the “SEC”), and (y) other documents filed or to be filed by DermTech with the SEC. DermTech cautions that the foregoing list of factors is not exclusive. You should not place undue reliance upon any forward-looking statements, which speak only as of the date made. DermTech does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.

DermTech

Sarah Dion

[email protected]

858.450.4222

Crowe PR

Sarah Gallagher

[email protected]

224.406.4709

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Nursing Surgery Genetics Practice Management Biotechnology Other Health Managed Care Health Pharmaceutical

MEDIA:

Logo
Logo

MSG Entertainment Provides Update on Construction of MSG Sphere in Las Vegas

MSG Entertainment Provides Update on Construction of MSG Sphere in Las Vegas

MSG Entertainment to Serve as Construction Manager; Jayne McGivern Named President of Development and Construction

AECOM to Continue Supporting Project Through New Services Agreement

Over the Next Year Team to Focus on Critical Path Construction Elements

NEW YORK–(BUSINESS WIRE)–
Madison Square Garden Entertainment Corp. (MSG Entertainment) (NYSE: MSGE) today provided an update on MSG Sphere at The Venetian, the Company’s planned state-of-the-art venue in Las Vegas, including that it has assumed the role of construction manager of the project. AECOM has transitioned from its role as general contractor to supporting MSG Sphere with a new services agreement that facilitates the company’s continued involvement through the project’s completion.

MSG Sphere Construction

MSG Entertainment, through a wholly-owned subsidiary, will manage construction of MSG Sphere in Las Vegas, with direct responsibility for strategic planning and the construction timeline, as well as management of all subcontractors.

The project will continue to be led by Jayne McGivern, who has been named President of Development and Construction. Ms. McGivern has assembled a world-class team of construction management professionals who will be responsible for driving the completion of the Las Vegas venue and retaining the knowledge gained for future MSG Sphere projects. MSG Entertainment’s internal team will direct all aspects of the project, including oversight of 30 seconded AECOM employees who will continue supporting key areas such as health and safety.

Ms. McGivern said: “We have taken significant steps to strengthen our internal construction team. This, along with valued support from AECOM, will give us greater transparency and control over the construction process, while enabling us to continue benefiting from AECOM’s expertise. MSG Sphere will be a venue unlike any other, and we believe we are well-positioned to not only advance our Las Vegas project, but also deliver on our long-term vision for MSG Sphere.”

Significant Progress

Significant progress has been made on construction of MSG Sphere in Las Vegas. Earlier this year, the superstructure reached its widest point with the completion of the venue’s sixth-level concrete ring beam, which is 490 feet wide and sits 113 feet above ground. The construction team recently completed the successful placement of two 240-ton steel girders that sit 140-feet off the ground and span the length of what will be the venue’s stage, paving the way for continued vertical construction.

Over the next year, construction efforts will focus on several of MSG Sphere’s critical path elements. Current work is being done to finish all superstructure concrete pours, which includes completing stair and elevator cores and the venue’s proscenium wall. Steel for the remaining exterior ring beams and inboard decks will then be placed, leading to the start of construction of the steel domed roof in early 2021.

As previously disclosed, MSG Entertainment expects to open MSG Sphere in Las Vegas in calendar 2023.

Jayne McGivern

Jayne McGivern joined MSG Entertainment (formerly part of The Madison Square Garden Company, which is now Madison Square Garden Sports Corp.) in 2018 and, prior to being named President of Development and Construction, served as Executive Vice President of Development and Construction. She will continue to oversee construction in Las Vegas, as well as the Company’s plans for a second MSG Sphere venue in London, which is pending necessary approvals. An established leader in global construction, Ms. McGivern has spearheaded the creation and delivery of a number of large development projects, including in her prior roles as CEO of the European Division of Multiplex plc, and Managing Director of Anschutz Entertainment Group in London, during its acquisition and redevelopment of The O2 (formerly the Millennium Dome). Ms. McGivern currently serves on the board of directors of Skanska AB, one of the world’s most prominent construction and development companies, and Cairn Homes, the leading Irish homebuilding company.

About Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp. (MSG Entertainment) is a leader in live entertainment experiences. The Company presents or hosts a broad array of events in its diverse collection of venues: New York’s Madison Square Garden, Hulu Theater at Madison Square Garden, Radio City Music Hall and Beacon Theatre; and The Chicago Theatre. MSG Entertainment is also building a new state-of-the-art venue in Las Vegas, MSG Sphere at The Venetian, and has announced plans to build a second MSG Sphere in London, pending necessary approvals. In addition, the Company features the original production – the Christmas Spectacular Starring the Radio City Rockettes – and through Boston Calling Events, produces the Boston Calling Music Festival. Also under the MSG Entertainment umbrella is Tao Group Hospitality, with entertainment dining and nightlife brands including Tao, Marquee, Lavo, Avenue, Beauty & Essex and Cathédrale. More information is available at www.msgentertainment.com.

All statements in this press release other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws including statements relating to the achievement of milestones and the expected opening date of the MSG Sphere in Las Vegas, as well as future economic and industry conditions. Investors are cautioned that any such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties. Important factors that could cause actual results to differ materially from forward-looking statements are set forth in MSG Entertainment’s filings with the U.S. Securities and Exchange Commission, including the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained therein. MSG Entertainment disclaims any obligation to update any forward-looking statements contained herein except as required by applicable law.

Kimberly Kerns

EVP and Chief Communications Officer

Madison Square Garden Entertainment Corp.

212-465-6442/[email protected]

KEYWORDS: Nevada New York United States North America

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property General Sports Sports Music General Entertainment Events/Concerts Entertainment

MEDIA:

Logo
Logo

Availability of the Q4 2020 Memorandum for modelling purposes

Availability of the Q4 2020 Memorandum for modelling purposes

 

Paris, France – December 17, 2020 – Sanofi announced today that its Q4 2020 Memorandum for modelling purposes is available on the “Investors” page of the company’s website:
https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2020

 

As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group’s quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency impact and share count. Sanofi’s fourth-quarter 2020 results will be published on February 5, 2021.

 

 

About Sanofi

 

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

 

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

 

Sanofi, Empowering Life

 

 

Media Relations Contact
Quentin Vivant
Tel.: +33 (0)1 53 77 46 46
[email protected]



Investor Relations Contact
Investor Relations team
Tel.: +33 (0)1 53 77 45 45
[email protected]


 


Sanofi Forward-Looking Statements


This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the  ultimate outcome of such litigation,  trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that COVID-19 will have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole.  Any material effect of COVID-19 on any of the foregoing could also adversely impact us. This situation is changing rapidly and additional impacts may arise of which we are not currently aware and may exacerbate other previously identified risks. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2019. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

 

Attachment



WashREIT Completes the Sale of Two Office Properties for $106.5 Million

WASHINGTON, Dec. 17, 2020 (GLOBE NEWSWIRE) — WashREIT (NYSE: WRE) announced that it has completed the sale of 1227 25th Street, NW and Monument II for a combined $106.5 million. The sale of Monument II, located in Herndon, VA, closed on December 2, 2020 and the sale of 1227 25th Street, located in Washington, DC, closed on December 17, 2020.

“These sales further strengthen our balance sheet ahead of the post-vaccine recovery and align with our strategy to reduce our exposure to office assets, allowing us to de-risk our portfolio and improve our ability to create long-term shareholder value,” said Paul T. McDermott, President and CEO of WashREIT. “We are pleased with the execution of these sales, which is a testament to the quality of our office tenants and the resilience of the DC Metro economy.”

WashREIT owns and operates uniquely positioned real estate assets in the Washington D.C. market. Backed by decades of experience, expertise and ambition, we create value by transforming insights into strategy and strategy into action. Our portfolio of 43 properties includes approximately 3.4 million square feet of commercial space and 6,863 multifamily apartment units. These 43 properties consist of 22 multifamily properties, 13 office properties, and 8 retail centers. Our shares trade on the NYSE and our company currently has an enterprise value of approximately $3 billion. With a track record of driving returns and delivering satisfaction, we are a trusted authority in one of the nation’s most competitive real estate markets.

Contact: Amy Hopkins
Phone: 202-774-3253
E-mail: [email protected]



Eagle Bancorp, Inc. Announces Cash Dividend and New Repurchase Program

BETHESDA, Md., Dec. 17, 2020 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc. (the “Company”) (NASDAQ: EGBN), the parent company for EagleBank, today announced a cash dividend for the fourth quarter of 2020, in the amount of $0.22 per share. The cash dividend will be payable on February 1, 2021 to shareholders of record on January 8, 2021.

Additionally, the Board of Directors adopted a new share repurchase program to take effect starting January 1, 2021, after the expiration of the current repurchase program on December 31, 2020. The Board of Directors authorized the repurchase of 1,588,848 shares of common stock, or approximately 5% of the Company’s outstanding shares of common stock, under the new repurchase program, which will expire on December 31, 2021, subject to earlier termination of the program by the Board of Directors. After lifting the suspension on the 2020 share repurchase program in the third quarter of 2020 and the repurchase of the remaining authorized 458,069 shares at a weighted average price of $37.72, the Company had 31,780,197 shares outstanding as of December 16, 2020.

Repurchases may be made in open market purchases, block trades or in privately negotiated transactions. Repurchases, if any, under the program will be made at the discretion of management, and will depend upon market pricing and conditions, business, legal, accounting and other considerations. Open market purchases will be conducted in accordance with the limitation of Rule 10b-18 of the Securities and Exchange Commission (the “SEC”). Repurchases may be made pursuant to any trading plan that may be adopted in accordance with SEC Rule 10b5-1, which would permit common stock to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. Under applicable law, repurchased shares will be cancelled and revert to the status of authorized but unissued shares.

The repurchase program may be modified, suspended or terminated at any time without notice, in the Company’s discretion, based upon a number of factors, including market conditions, the cost of repurchasing shares, the availability of alternative investment opportunities, liquidity, the need for capital in the Company’s operations and other factors deemed appropriate. These factors may also affect the timing and amount of share repurchases. The repurchase program does not obligate the Company to repurchase any shares.

About Eagle Bancorp: The Company is the holding company for EagleBank, which commenced operations in 1998. The Bank is headquartered in Bethesda, Maryland, and operates through twenty branch offices, located in Suburban Maryland, Washington, D.C. and Northern Virginia. The Company focuses on building relationships with businesses, professionals and individuals in its marketplace.

Caution About Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Securities Exchange Act of 1934, as amended, including statements of goals, intentions, and expectations as to future trends, plans, events or results of Company operations and policies and regarding general economic conditions. These forward-looking statements are based on current expectations that involve risks, uncertainties and assumptions, including the impacts of the novel coronavirus pandemic and the volatility and uncertainty in global markets and economies. Because of these uncertainties and the assumptions on which the forward-looking statements are based, actual future operations and results in the future may differ materially from those indicated herein. Readers are cautioned against placing undue reliance on any such forward-looking statements. For details on factors that could affect these expectations, see the risk factors and other cautionary language included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020, and other filings with the SEC. Except as required by law, the Company does not undertake to update forward-looking statements contained in this release.

EagleBank Contact
Dave Danielson
301.986.1800



NVIDIA Announces Upcoming Events for Financial Community

SANTA CLARA, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) — NVIDIA will present at the following events for the financial community:

J.P. Morgan Healthcare Conference

Monday, Jan. 11, at 1:30 p.m. Pacific time
 
J.P. Morgan Tech/Auto Forum

Tuesday, Jan. 12, at 7:50 a.m. Pacific time 
 
Goldman Sachs Technology & Internet Conference

Tuesday, Jan. 12, at 12:40 p.m. Pacific time

Interested parties can listen to the live audio webcasts of NVIDIA’s presentations at these events, available at investor.nvidia.com. Replays of the webcasts will be available for 90 days afterward.

About NVIDIA

NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined modern computer graphics and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI — the next era of computing — with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world. More information at https://nvidianews.nvidia.com/.

For further information, contact:  
Simona Jankowski Robert Sherbin
Investor Relations Corporate Communications
NVIDIA Corporation NVIDIA Corporation

[email protected]

[email protected]

© 2020 NVIDIA Corporation. All rights reserved. NVIDIA and the NVIDIA logo are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Other company and product names may be trademarks of the respective companies with which they are associated. Features, pricing, availability, and specifications are subject to change without notice.



Komutel’s Recording Software, Komlog, Release 1.18 Now Compatible with KENWOOD KAIROS DMR

ST-GEORGES, Québec, Dec. 17, 2020 (GLOBE NEWSWIRE) — Komutel, a leading unified communication solution developer, today announced that its recording software Komlog can now interface with the KENWOOD KAIROS DMR solution from EFJohnson, a JVCKENWOOD company. KAIROS repeaters are the ideal platform for any DMR application, from simple stand-alone sites to large nationwide systems.

Komlog is a web-based recording application known for its ease of use and versatility, and it is now compliance-tested with KAIROS DMR.

Quotes:

“We are very proud that our recording software Komlog can now interface with KENWOOD KAIROS DMR. Komlog is a powerful solution for enterprises of all sizes as it is the key to efficient communications. With this testing, customers can confidently use Komlog to capture audio and metadata from their KAIROS DMR systems.”
— Richard Poulin, CEO, Komutel

About Komutel
Komutel is an Enterprise Communication Software Developer, specializing in the development and marketing of open-ended and innovative solutions in the telecommunications sector. Komutel, leader in network and platform integration solutions (IT, VoIP, UC, Voice Mail, Mobility, Radio), is a recognized provider of user-friendly, versatile and value-added solutions. Komutel customers span across many industry sectors such as Health Care, Finance, Insurance, Public Safety, Education and more. Komutel “Kloud” solutions’ portfolio includes: call center applications, Inbound Intelligence Integration, CDR reporting, PC Consoles, IVR, Call Recording, as well as various business specific modules, respectively maximizing communication performance in their industry sectors. Komutel suite of products, available in the “cloud” or as a premise based, reinvents the basics and adds significant meaning to customers’ unified communications solutions. For more information, visit our website: www.komutel.com

About EF Johnson Technologies, Inc.

EF Johnson Technologies, Inc. is an independent subsidiary of JVCKENWOOD Corporation. Headquartered in Irving, Texas, EFJohnson focuses on innovating, developing and marketing the highest quality secure communications solutions to organizations whose mission is to protect and save lives. Our customers include first responders in public safety and public service, the federal government, and industrial organizations. For more information, visit www.efjohnson.com.

About JVCKENWOOD Corporation
JVCKENWOOD is a global manufacturer specializing in Automotive and Professional System Solutions. JVCKENWOOD operates four business segments, Car Electronics, Professional Systems, Optical & Audio, and Entertainment Software with image, sound, and radio technologies, as well as infotainment and visual software. JVCKENWOOD creates excitement and peace of mind while aiming to achieve profitable growth and become a business group that is widely trusted by society. For more information, visit https://www.jvckenwood.com/en.html.


Media Inquiries:


Genevieve Thibodeau
418-225-9988
[email protected]



Two of First Trust ETFs Based on NASDAQ® Indexes Surpass $1 Billion in AUM

Two of First Trust ETFs Based on NASDAQ® Indexes Surpass $1 Billion in AUM

WHEATON, Ill.–(BUSINESS WIRE)–First Trust Advisors L.P. (“First Trust”), a leading exchange-traded fund (“ETF”) provider and asset manager, announced today that two of its ETFs based on Nasdaq indexes are celebrating a milestone. The First Trust NASDAQ-100 Equal Weighted Index Fund (NASDAQ: QQEW) and the First Trust NASDAQ® Clean Edge® Green Energy Index Fund (NASDAQ: QCLN) (collectively, “funds”) each surpassed $1 billion in assets under management (“AUM”) as of 11/30/20.

QQEW seeks to replicate as closely as possible (before the fund’s fees and expenses) the price and yield of the NASDAQ-100 Equal Weighted Index℠. QQEW’s equal-weighted methodology seeks to avoid the top-heavy concentration common to many market-cap weighted indices and may be appealing to investors who are looking to reduce stock specific risk. “For many years the NASDAQ-100 Index® has included some of the most innovative and dynamic companies in the world. The equally-weighted approach employed by QQEW provides investors more balanced exposure to these stocks than a market-cap weighted index methodology,” said Ryan Issakainen, CFA, Senior Vice President, ETF Strategist at First Trust. As of 10/30/20, the top 10 holdings in the NASDAQ-100 Index® represented more than 58% of the index. QQEW allocates a total of 10% in these same top 10 companies at each rebalance.

QCLN provides a broad, diversified approach to the theme of clean energy. The fund seeks investment results that correspond generally to the price and yield (before the fund’s fees and expenses) of an equity index called the NASDAQ® Clean Edge® Green Energy Index℠. “Green and renewable energy has been one of our favorite investment themes this year, and we believe it has reached a tipping point, as costs have declined dramatically over the past few years and become competitive with traditional power sources. QCLN provides a more balanced approach to this theme, providing exposure to various aspects of green energy, including solar power, wind power, advanced batteries, electric vehicles and others,” said Issakainen.

QQEW and QCLN reached a combined total of over $2.6 billion in AUM, as of 11/30/20.

For more information about First Trust, please contact Ryan Issakainen at (630) 765-8689 or [email protected].

About First Trust

First Trust is a federally registered investment advisor and serves as the fund’s investment advisor. First Trust and its affiliate First Trust Portfolios L.P. (“FTP”), a FINRA registered broker-dealer, are privately held companies that provide a variety of investment services. First Trust has collective assets under management or supervision of approximately $164 billion as of November 30, 2020 through unit investment trusts, exchange-traded funds, closed-end funds, mutual funds and separate managed accounts. First Trust is the supervisor of the First Trust unit investment trusts, while FTP is the sponsor. FTP is also a distributor of mutual fund shares and exchange-traded fund creation units. First Trust and FTP are based in Wheaton, Illinois. For more information, visit http://www.ftportfolios.com.

You should consider the funds’ investment objectives, risks, and charges and expenses carefully before investing. Contact First Trust Portfolios L.P. at 1-800-621-1675 to obtain a prospectus or summary prospectus which contains this and other information about the funds. The prospectus or summary prospectus should be read carefully before investing.

ETF Characteristics

The funds list and principally trade their shares on The Nasdaq Stock Market LLC.

QQEW’s return may not match the return of the NASDAQ-100 Equal Weighted IndexSM. QCLN’s return may not match the return of the NASDAQ Clean Edge® Green Energy Index. Securities held by the fund will generally not be bought or sold in response to market fluctuations.

Investors buying or selling fund shares on the secondary market may incur customary brokerage commissions. Market prices may differ to some degree from the net asset value of the shares. Investors who sell fund shares may receive less than the share’s net asset value. Shares may be sold throughout the day on the exchange through any brokerage account. However, unlike mutual funds, shares may only be redeemed directly from the fund by authorized participants, in very large creation/redemption units. If the fund’s authorized participants are unable to proceed with creation/redemption orders and no other authorized participant is able to step forward to create or redeem, fund shares may trade at a discount to the fund’s net asset value and possibly face delisting.

Risk Considerations

The funds’ shares will change in value and you could lose money by investing in the funds. One of the principal risks of investing in the funds is market risk. Market risk is the risk that a particular security owned by the funds, fund shares or securities in general may fall in value. There can be no assurance that the funds’ investment objective will be achieved. The outbreak of the respiratory disease designated as COVID-19 in December 2019 has caused significant volatility and declines in global financial markets, which have caused losses for investors. The COVID-19 pandemic may last for an extended period of time and will continue to impact the economy for the foreseeable future.

The funds may invest in securities issued by companies concentrated in a particular sector which involves additional risks including limited diversification. The funds may invest in small capitalization and mid capitalization companies. Such companies may experience greater price volatility than larger, more established companies.

Renewable and alternative energy companies can be significantly affected by obsolescence of existing technology, short product cycles, legislation resulting in more strict government regulations and enforcement policies, fluctuations in energy prices and supply and demand of alternative energy fuels, energy conservation, the success of exploration projects, the supply of and demand for oil and gas, world events and economic conditions. Shares of clean energy companies have been significantly more volatile than shares of companies operating in other more established industries. This industry is relatively nascent and under-researched in comparison to more established and mature sectors.

QCLN is classified as “non-diversified” and may invest a relatively high percentage of its assets in a limited number of issuers. As a result, the fund may be more susceptible to a single adverse economic or regulatory occurrence affecting one or more of these issuers, experience increased volatility and be highly concentrated in certain issuers.

First Trust Advisors L.P. is the adviser to the funds. First Trust Advisors L.P. is an affiliate of First Trust Portfolios L.P., the funds’ distributor.

Please see each fund’s prospectus for a complete list of all the risks of investing in the funds.

The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgement in determining whether investments are appropriate for their clients.

Nasdaq®, NASDAQ-100®, NASDAQ-100 Index®, NASDAQ-100 Equal Weighted Index℠, Clean Edge® and NASDAQ® Clean Edge® Green Energy Index℠ are registered trademarks and service marks of Nasdaq, Inc. and Clean Edge, Inc., respectively (together with its affiliates hereinafter referred to as the “Corporations”) and are licensed for use by First Trust. The Fund has not been passed on by the Corporations as to its legality or suitability. The Funds are not issued, endorsed, sold or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE FUNDS.

Ryan Issakainen

First Trust

(630) 765-8689

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Logo
Logo

AAR Reports Second Quarter Fiscal Year 2021 Results

  • Second quarter sales of $404 million, down 28% from the prior year reflecting the impact of COVID-19
  • Second quarter GAAP diluted earnings per share from continuing operations of $0.41
  • Adjusted diluted earnings per share from continuing operations of $0.31, which excludes the impact of CARES Act support and other items
  • Cash flow from operating activities from continuing operations of $28 million

WOOD DALE, Ill., Dec. 17, 2020 (GLOBE NEWSWIRE) — AAR CORP. (NYSE: AIR) today reported second quarter Fiscal Year 2021 consolidated sales of $403.6 million and income from continuing operations of $14.4 million, or $0.41 per diluted share. For the second quarter of the prior year, the Company reported sales of $560.9 million and income from continuing operations of $20.1 million, or $0.57 per diluted share. Our adjusted diluted earnings per share from continuing operations in the second quarter of Fiscal Year 2021 were $0.31 compared to $0.64 in the second quarter of the prior year. Current quarter results included net pretax adjustments of $4.7 million, or $0.10 per share, primarily related to the exclusion of CARES Act support partially offset by contract restructuring and exit costs.

Consolidated second quarter sales decreased 28% from the prior year quarter. Our consolidated sales to commercial customers decreased 48% from the prior year quarter primarily due to the continued impact of COVID-19. Our consolidated sales to government customers increased 13% due to strong performance on existing government contracts.

Sales to government and defense customers were 52% of consolidated sales compared to 33% in the prior year’s quarter reflecting growth from government contract awards and the continued impact of COVID-19 on commercial volumes.

Gross profit margins increased to 17.2% in the current quarter from 15.3% in the prior year quarter due primarily to the CARES Act payroll support. Gross profit margins also increased sequentially from 12.1% in the first quarter primarily due to improved operating efficiencies.

During the quarter, we were awarded a five-year, $148.4 million follow-on contract by the Naval Air Systems Command to perform contractor logistics services for the U.S. Navy’s C-40A fleet. This expanded award introduces additional services including new operating sites, commercial line maintenance and scheduled engine overhauls, which reinforce our role as a trusted partner applying commercial best practices to provide quality and value to our government customers.

Subsequent to the end of the quarter, we announced several new contract awards including:

  • Exclusive seven-year partnership with Fortress Transportation and Infrastructure Investors to manage the teardown, repair, marketing and sales from its growing CFM56 engine pool which currently totals over 200 engines
  • Ten-year agreement with Honeywell to be the sole licensee for component repair and overhaul services for its suite of Electronic Bleed Air Systems on the B737 MAX aircraft
  • Extension of our agreement with Viasat to provide logistics, repair and aftermarket management services for its in-flight connectivity products
  • Three-year Airinmar agreement to provide aircraft warranty solutions for Volaris, Mexico’s leading domestic airline

“The actions we have taken over the past three quarters during the pandemic drove a meaningful sequential improvement to our margins in a stable revenue environment. We expect the combination of our improved operating efficiency, growth from new business wins, and the commercial market recovery will continue to drive margin expansion,” said John M. Holmes, President and Chief Executive Officer of AAR CORP.

Selling, general and administrative expenses decreased to $43.4 million from $57.1 million reflecting the impact of our actions to reduce both our fixed and variable cost structure. As a percentage of sales, selling, general and administrative expenses were 10.8% for the quarter compared to 10.2% last year as a result of the significant decrease in commercial sales more than offsetting the favorable impact from the cost reduction actions.

Net interest expense for the quarter was $1.3 million compared to $1.8 million last year. Average diluted share count was 35.0 million in both the current and prior year quarters.

Cash flow provided by operating activities from continuing operations was $27.6 million during the current quarter compared to cash flow of $19.9 million in the prior year quarter. Excluding our accounts receivable financing program, our cash flow provided by operating activities from continuing operations was $34.4 million in the current quarter compared to cash flow of $20.4 million in the prior year quarter.

Holmes concluded, “As a result of the strength of our government business, significant cost reductions and our focus on managing working capital, we have generated cash and preserved our low cost debt capital structure despite the impact of COVID-19 on our commercial business. Additionally, the funds received under the CARES Act have allowed us to retain our skilled workforce. We believe our strong balance sheet and the increased customer focus on our lower cost, value-add solutions will enable us to continue to capitalize on growth opportunities as the commercial market recovers.”

Conference Call Information

AAR will hold its quarterly conference call at 3:45 p.m. CT on December 17, 2020. The conference call can be accessed by calling 866-802-4322 from inside the U.S. or +1-703-639-1319 from outside the U.S. A replay of the conference call will also be available by calling 855-859-2056 from inside the U.S. or +1-404-537-3406 from outside the U.S. (access code 7094273). The replay will be available from 7:15 p.m. CT on December 17, 2020 until 10:59 p.m. CT on December 22, 2020.

About AAR

AAR is a global aerospace and defense aftermarket solutions company with operations in over 20 countries. Headquartered in the Chicago area, AAR supports commercial and government customers through two operating segments: Aviation Services and Expeditionary Services. AAR’s Aviation Services include parts supply; OEM solutions; integrated solutions; maintenance, repair, overhaul; and engineering. AAR’s Expeditionary Services include mobility systems operations. Additional information can be found at www.aarcorp.com.

Contact: Dylan Wolin – Vice President, Strategic & Corporate Development and Treasurer | (630) 227-2017 | [email protected]

 
This press release contains certain statements relating to future results, which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, which reflect management’s expectations about future conditions, including but not limited to, (i) the ability to drive meaningful sequential improvement to our margins in a stable revenue environment, (ii) the ability to maintain our role as a trusted partner applying commercial best practices to provide quality and value to our government customers, (iii) the expectation that the new business wins will accelerate our recovery as they ramp-up over the coming months, (iv) the expectation that the combination of our improved operating efficiency, growth from new business wins, and the commercial market recovery will continue to drive margin expansion, (v) the expectation that the strength of our government business, significant cost reductions and our focus on managing working capital, will generate cash and preserve our low cost debt capital structure despite the impact of COVID-19 on our commercial business, (vi) the expectation that the funds received under the CARES Act will allow us to retain our skilled workforce, and (vii) the belief that our strong balance sheet and the increased customer focus on our lower cost, value-add solutions will enable us to continue to capitalize on growth opportunities as the commercial market recovers.

Forward-looking statements may also be identified because they contain words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would,” or similar expressions and the negatives of those terms.

These forward-looking statements are based on beliefs of Company management, as well as assumptions and estimates based on information currently available to the Company, and are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or those anticipated, depending on a variety of factors, including: (i) factors that adversely affect the commercial aviation industry; (ii) the impact of the COVID-19 pandemic on air travel, worldwide commercial activity and our and our customers’ ability to source parts and components; (iii) a reduction in the level of sales to the branches, agencies and departments of the U.S. government and their contractors (which were 32.2% of total sales in fiscal 2020); (iv) non-compliance with laws and regulations relating to the formation, administration and performance of our U.S. government contracts; (v) cost overruns and losses on fixed-price contracts; (vi) nonperformance by subcontractors or suppliers; (vii) changes in or non-compliance with laws and regulations that may affect certain of our aviation and government and defense related activities that are subject to licensing, certification and other regulatory requirements imposed by the FAA, the U.S. State Department and other regulatory agencies, both domestic and foreign; (viii) a reduction in outsourcing of maintenance activity by airlines; (ix) a shortage of the skilled personnel on whom we depend to operate our business, or work stoppages; (x) competition from other companies, including original equipment manufacturers, some of which have greater financial resources than we do; (xi) financial and operational risks arising as a result of operating internationally; (xii) inability to integrate acquisitions effectively and execute our operational and financial plan related to the acquisitions; (xiii) inability to recover our costs due to fluctuations in market values for aviation products and equipment caused by various factors, including reductions in air travel, airline bankruptcies, consolidations and fleet reductions; (xiv) asset impairment charges we may be required to recognize to reflect the non-recoverability of our assets or lowered expectations regarding businesses we have acquired; (xv) limitations on our ability to access the debt and equity capital markets or to draw down funds under loan agreements; (xvi) non-compliance with restrictive and financial covenants contained in certain of our loan agreements; (xvii) failure to maintain or pay dividends; (xviii) exposure to product liability and property claims that may be in excess of our liability insurance coverage; (xix) threats to our systems technology from equipment failures and/or cybersecurity breaches; (xx) the costs of compliance, and liability for non-compliance, with environmental regulations, including future requirements regarding climate change; and (xxi) a need to make significant capital expenditures to keep pace with technological developments in our industry.

For a discussion of these and other risks and uncertainties, refer to “Risk Factors” in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. These events and uncertainties are difficult or impossible to predict accurately and many are beyond the Company’s control. The Company assumes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.


AAR CORP. and Subsidiaries

       

Consolidated Statements of Operations


(In millions except per share data – unaudited)
Three Months Ended

November 30,
  Six Months Ended

November 30,
 
2020
2019  
2020



  2019
       
Sales $
403.6
    $560.9     $
804.4
    $1,102.4  
Cost and expenses:              
Cost of sales   334.1       475.0       686.3       934.9  
Provision for doubtful accounts   4.4       0.7       4.4       1.4  
Selling, general and administrative   43.4       57.1       88.7       115.2  
Loss from joint ventures   (0.1 )     ––       (0.2 )     ––  
               
Operating income   21.6       28.1       24.8       50.9  
Loss on sale of business   ––       ––       (19.5 )     ––  
Interest expense, net   (1.3 )     (1.8 )     (2.9 )     (3.9 )
Other expense, net   (0.7 )     (0.2 )     (0.5 )     (0.4 )
               
Income from continuing operations before income tax expense   19.6       26.1       1.9       46.6  
Income tax expense   5.2       6.0       1.4       9.4  
Income from continuing operations   14.4       20.1       0.5       37.2  
Loss from discontinued operations   (6.2 )     (5.9 )     (6.8 )     (18.6 )
Net income (loss) $
8.2
    $14.2     $
(6.3
)   $18.6  
               
Earnings (Loss) per share – Basic:              
Earnings from continuing operations $
0.41
    $0.58     $
0.01
    $1.07  
Loss from discontinued operations   (0.18 )     (0.17 )     (0.20 )     (0.54 )
Earnings (Loss) per share – Basic $
0.23
    $0.41     $
(0.19
)   $0.53  
               
Earnings (Loss) per share – Diluted:              
Earnings from continuing operations $
0.41
    $0.57     $
0.01
    $1.06  
Loss from discontinued operations   (0.18 )     (0.17 )     (0.19 )     (0.53 )
Earnings (Loss) per share – Diluted $
0.23
    $0.40     $
(0.18
)   $0.53  
               
Share Data:              
Weighted average shares outstanding – Basic   34.9       34.6       34.9       34.6  
Weighted average shares outstanding – Diluted   35.0       35.0       35.0       35.0  


AAR CORP. and Subsidiaries



Consolidated Balance Sheets


(In millions)
November 30,


2020
  May 31,


2020
  (unaudited)    
ASSETS      
Cash and cash equivalents $
110.0
  $404.7
Restricted cash   3.0     20.0
Accounts receivable, net   169.8     171.9
Contract assets   52.8     49.3
Inventories, net   585.0     623.1
Rotable assets and equipment on or available for lease   59.4     69.6
Assets of discontinued operations   21.2     22.9
Other current assets   40.5     77.2
Total current assets   1,041.7     1,438.7
Property, plant, and equipment, net   125.0     135.7
Operating lease right-of-use assets, net   83.3     89.7
Goodwill and intangible assets, net   122.6     121.7
Rotable assets supporting long-term programs   200.5     211.7
Other non-current assets   96.2     81.5
Total assets $
1,669.3
  $2,079.0
       
LIABILITIES AND EQUITY      
Accounts payable and accrued liabilities $
375.0
  $353.2
Liabilities of discontinued operations   33.2     29.9
Total current liabilities   408.2     383.1
Long-term debt   220.3     600.0
Operating lease liabilities   66.0     70.9
Other liabilities and deferred income   74.1     122.4
Total liabilities   768.6     1,176.4
Equity   900.7     902.6
Total liabilities and equity $
1,669.3
  $2,079.0





AAR CORP. and Subsidiaries


Consolidated Statements of Cash Flows


(In millions – unaudited)
Three Months Ended

November 30,
  Six Months Ended

November 30,
   
2020
      2019      
2020
      2019  
Cash flows provided from operating activities:              
Net income (loss) $
8.2
    $14.2     $
(6.3
)   $18.6  
Loss from discontinued operations   6.2       5.9       6.8       18.6  
Income from continuing operations   14.4       20.1       0.5       37.2  
Adjustments to reconcile income from continuing operations to net cash 
provided from (used in) operating activities
             
Depreciation and intangible amortization   9.2       11.0       18.2       21.8  
Amortization of stock-based compensation   1.8       2.8       4.5       7.1  
Provision for doubtful accounts   4.4       0.7       4.4       1.4  
Loss on sale of business   ––       ––       19.5       ––  
Customer contract termination costs   ––       ––       2.2       ––  
Impairment charges   1.2       ––       7.0       ––  
Changes in certain assets and liabilities:              
Accounts receivable   (7.5 )     (10.4 )     (4.8 )     (11.0 )
Contract assets   (7.4 )     (0.1 )     (7.5 )     (2.8 )
Inventories   11.4       (26.8 )     30.2       (56.8 )
Rotable assets supporting long-term programs   (1.9 )     (5.3 )     (0.9 )     (19.1 )
Accounts payable and accrued liabilities   34.1       19.6       9.0       24.6  
Payroll Support Program deferred credit   (17.2 )     ––       23.6       ––  
Deferred revenue on long-term programs   (42.5 )     39.5       (60.4 )     23.3  
Other   27.6       (31.2 )     21.9       (35.9 )
Net cash provided from (used in) operating activities – continuing operations   27.6       19.9       67.4       (10.2 )
Net cash provided from (used in) operating activities – discontinued operations   (1.0 )     (5.4 )     (1.9 )     (7.7 )
Net cash provided from (used in) operating activities   26.6       14.5       65.5       (17.9 )
               
Cash flows provide from (used in) investing activities:              
Property, plant and equipment expenditures   (2.7 )     (5.7 )     (6.0 )     (10.2 )
Proceeds from termination of life insurance policies   10.0       ––       10.0       ––  
Other   ––       (2.5 )     1.6       (1.5 )
Net cash provided from (used in) investing activities – continuing operations   7.3       (8.2 )     5.6       (11.7 )
               
Cash flows provided from financing activities:              
Proceeds from (repayments on) borrowings, net   (35.0 )     (5.0 )     (381.3 )     55.0  
Cash dividends   ––       (2.6 )     (0.1 )     (5.5 )
Purchase of treasury stock   ––       (4.1 )     ––       (4.1 )
Other   ––       ––       (1.5 )     (4.3 )
Net cash provided from (used in) financing activities – continuing operations   (35.0 )     (11.7 )     (382.9 )     41.1  
Effect of exchange rate changes on cash   ––       0.1       0.1       0.1  
Increase (Decrease) in cash and cash equivalents   (1.1 )     (5.3 )     (311.7 )     11.6  
Cash, cash equivalents, and restricted cash at beginning of period   114.1       58.0       424.7       41.1  
Cash, cash equivalents, and restricted cash at end of period $
113.0
    $52.7     $
113.0
    $52.7  





AAR CORP. and Subsidiaries


Sales By Business Segment


(In millions – unaudited)
Three Months Ended

November 30,
  Six Months Ended

November 30,
    2020   2019     2020   2019
Aviation Services $
385.0
$532.0   $
748.6
$1,043.8
Expeditionary Services   18.6   28.9     55.8   58.6
  $
403.6
$560.9   $
804.4
$1,102.4


Gross Profit by Business Segment


(In millions- unaudited)
Three Months Ended

November 30,
  Six Months Ended

November 30,
    2020   2019     2020   2019
Aviation Services $
66.8
$85.7   $
111.4
$165.7
Expeditionary Services   2.7   0.2     6.7   1.8
  $69.5 $85.9   $
118.1
$167.5

Adjusted income from continuing operations, adjusted diluted earnings per share from continuing operations, adjusted operating income, adjusted operating income margin, adjusted sales, adjusted selling, general, and administrative expenses, adjusted cash flow from provided by (used in) operating activities from continuing operations, adjusted EBITDA, and net debt are “non-GAAP financial measures” as defined in Regulation G of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We believe these non-GAAP financial measures are relevant and useful for investors as they illustrate our actual operating performance unaffected by the impact of certain items. When reviewed in conjunction with our GAAP results and the accompanying reconciliations, we believe these non-GAAP financial measures provide additional information that is useful to gain an understanding of the factors and trends affecting our business and provide a means by which to compare our operating performance against that of other companies in the industries we compete. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Adjusted EBITDA is income from continuing operations before interest income (expense), other income (expense), income taxes, depreciation and amortization, stock-based compensation and other items of an unusual nature including but not limited to business divestitures, workforce actions, subsidies and costs, impairment charges, facility consolidation and repositioning costs, investigation and remediation compliance costs, and significant customer events such as early terminations, contract restructurings, and bankruptcies.

Pursuant to the requirements of Regulation G of the Exchange Act, we are providing the following tables that reconcile the above mentioned non-GAAP financial measures to the most directly comparable GAAP financial measures:


Adjusted Income from Continuing Operations



(a)



(In millions – unaudited)
Three Months Ended

November 30,
  Six Months Ended

November 30,
    2020     2019     2020     2019
Income from continuing operations $
14.4
  $20.1   $
0.5
  $37.2
Investigation and remediation compliance costs   2.1     1.8     3.1     4.2
Loss on sale of business   ––     ––     14.8     ––
Contract termination and restructuring costs, net   3.3     ––     5.1     ––
Customer bankruptcy charges   1.0     ––     1.1     ––
Asset impairment charges   1.0     ––     5.4     ––
Government workforce subsidies   (14.2 )   ––     (22.6 )   ––
Facility consolidation and repositioning costs   0.3     ––     1.8     ––
Severance, furlough and pension settlement charges   2.4     0.7     6.9     1.2
Strategic financing evaluation costs   0.6     ––     0.8     ––
Adjusted income from continuing operations $
10.9
  $22.6   $
16.9
  $42.6

(a)  All adjustments are presented net of applicable income taxes.


Adjusted Diluted Earnings per Share from Continuing Operations



(a)



(In millions – unaudited)
Three Months
Ended


November 30,
  Six Months

Ended

November 30,
    2020     2019     2020     2019
Diluted earnings per share from continuing operations $
0.41
  $0.57   $
0.01
  $1.06
Investigation and remediation compliance costs   0.06     0.05     0.09     0.12
Loss on sale of business   ––     ––     0.42     ––
Contract termination and restructuring costs, net   0.10     ––     0.15     ––
Customer bankruptcy charge   0.04     ––     0.04     ––
Asset impairment charges   0.02     ––     0.15     ––
Government workforce subsidies   (0.41 )   ––     (0.65 )   ––
Facility consolidation and repositioning costs   0.01     ––     0.05     ––
Severance, furlough and pension settlement charges   0.07     0.02     0.20     0.03
Strategic financing evaluation costs   0.01     ––     0.02     ––
Adjusted diluted earnings per share from continuing operations $
0.31
  $0.64   $
0.48
  $1.21

(a)  All adjustments are presented net of applicable income taxes.


Adjusted Operating Margin


(In millions – unaudited)
Three Months Ended
 
  November 30,
2020
August 31,
2020
 
Operating income $
21.6
  $3.2    
Investigation and remediation compliance costs   2.8     1.3    
Contract termination and restructuring costs, net   4.5     2.2    
Customer bankruptcy charge   1.3     0.2    
Asset impairment charges   1.2     5.8    
Government workforce subsidies   (18.7 )   (11.1 )  
Facility consolidation and repositioning costs   0.4     2.0    
Severance and furlough costs   2.2     6.0    
Strategic financing evaluation costs   0.7     0.3    
Adjusted operating income $
16.0
  $9.9    
       
Sales $
403.6
  $400.8    
Contract termination and restructuring costs, net   (2.3 )   1.9    
Customer bankruptcy charge   0.4     ––    
Adjusted sales $
401.7
  $402.7    
       
Adjusted operating margin   4.0 %   2.5 %  


Adjusted Selling, General and Administrative Expenses


(In millions – unaudited)
Three Months
Ended


November 30,
  Six Months

Ended

November 30,
    2020     2019       2020     2019  
Selling, general and administrative expenses $
43.4
  $57.1     $
88.7
  $115.2  
Investigation and remediation compliance costs   (2.8 )   (2.4 )     (4.1 )   (5.2 )
Severance and furlough costs   (0.7 )   (0.9 )     (3.0 )   (1.7 )
Government workforce subsidies   0.6     ––       1.6     ––  
Strategic financing evaluation costs   (0.7 )   ––       (1.0 )   ––  
Stock-based compensation   (1.8 )   (2.8 )     (4.5 )   (7.1 )
Adjusted selling, general and administrative expenses $
38.0
  $51.0     $
77.7
  $101.2  


Adjusted Cash Provided by (Used in) Operating Activities from


   

Continuing Operations


(In millions – unaudited)
Three Months
Ended


November 30,
  Six Months

Ended

November 30,
    2020     2019       2020     2019  
Cash provided by (used in) operating activities from 
continuing operations
$
27.6
  $19.9     $
67.4
  $(10.2 )
Amounts outstanding on accounts receivable financing program:          
Beginning of period   55.7     86.2       74.3     86.2  
End of period   (48.9 )   (85.7 )     (48.9 )   (85.7 )
Adjusted cash provided by (used in) operating activities 
from continuing operations
$
34.4
  $20.4     $
92.8
  $(9.7 )


Adjusted EBITDA


(In millions – unaudited)
Three Months Ended

November 30,
  Six Months Ended

November 30,
  Year Ended
May 31,
    2020     2019     2020     2019     2020  
Net income (loss) $
8.2
  $14.2   $
(6.3
) $18.6   $4.4  
Loss from discontinued operations   6.2     5.9     6.8     18.6     20.4  
Income tax expense   5.2     6.0     1.4     9.4     5.6  
Other expense, net   0.7     0.2     0.5     0.4     2.1  
Interest expense, net   1.3     1.8     2.9     3.9     8.8  
Depreciation and intangible amortization   9.2     11.0     18.2     21.8     43.7  
Investigation and remediation costs   2.8     2.4     4.1     5.5     10.1  
Loss on sale of business   ––     ––     19.5     ––     ––  
Asset impairment charges   1.2     ––     7.0     ––     11.0  
Contract termination and restructuring costs, net   4.5     ––     6.7     ––     31.3  
Customer bankruptcy charge   1.3     ––     1.5     ––     1.6  
Government workforce subsidies   (18.7 )   ––     (29.8 )   ––     (2.8 )
Facility consolidation and repositioning costs   0.4     ––     2.4     ––     4.9  
Severance and furlough costs   2.2     0.9     8.2     1.6     7.1  
Strategic financing evaluation costs   0.7     ––     1.0     ––     0.4  
Stock-based compensation   1.8     2.8     4.5     7.1     7.3  
Adjusted EBITDA $
27.0
  $45.2   $
48.6
  $86.9   $155.9  


Net Debt


(In millions- unaudited)
November 30,
2020
  November 30,
2019



 
Total debt $
222.1
    $198.3    
Less: Cash and cash equivalents   (110.0 )     (38.2 )  
Net debt $
112.1
    $160.1    


Net Debt to Adjusted EBITDA


(In millions – unaudited)
   
Adjusted EBITDA for the year ended May 31, 2020 $
155.9
   
Less: Adjusted EBITDA for the six months ended November 30, 2019   (86.9 )  
Plus: Adjusted EBITDA for the six months ended November 30, 2020  
48.6
   
Adjusted EBITDA for the twelve months ended November 30, 2020
$


117


.


6
   
Net debt at November 30, 2020 $
112.1
   
Net debt to Adjusted EBITDA
  0.95    

 



United States Steel Corporation Provides Fourth Quarter 2020 Guidance

United States Steel Corporation Provides Fourth Quarter 2020 Guidance

PITTSBURGH–(BUSINESS WIRE)–
United States Steel Corporation (NYSE: X) today provided fourth quarter 2020 guidance. Fourth quarter 2020 adjusted EBITDA is expected to be approximately $55 million. The Company expects fourth quarter 2020 adjusted diluted loss per share to be approximately ($0.85).

“Flat-rolled customer demand in the U.S. and Europe has improved throughout the fourth quarter, fueled by consumer-driven end-markets such as automotive, appliance, and packaging,” commented U. S. Steel President and Chief Executive Officer David B. Burritt. “December’s performance has been particularly strong driven by the flow-through of higher steel prices, more nimble operations, and a continued focus on cost management. As a result, we have line of sight to significantly improved financial performance in 2021. Longer lead times, higher utilization rates, and higher input costs reflect current healthy steel demand and make us optimistic about the sustainability of today’s market environment.”

Adjusted EBITDA Commentary

Our Flat-rolled segment is expected to generate positive EBITDA in the fourth quarter. Our order book remains strong across key strategic markets and higher steel prices are being more fully reflected in our adjustable contract business. This market backdrop informed our decision to restart blast furnace #4 at Gary Works and iron ore production at our Keetac mine to ensure we continue to satisfy strong customer demand. We expect to benefit from improved efficiencies as we exit the year.

In Europe, customer demand continues to be strong. Improved commercial performance and a focus on cost management are expected to more than offset raw material headwinds from higher iron ore prices. As a result, fourth quarter results should exceed third quarter performance.

In Tubular, customer activity remains range bound. Higher rig counts are not yet resulting in higher shipments as distributors manage inventories into year-end. We remain focused on what we can control, including the start-up of our electric arc furnace (EAF) at Tubular where we produced first rounds for seamless pipe production at the end of October. The in-sourcing of rounds production is already beginning to improve the segment’s cost structure in the fourth quarter.

Forward Looking Statements

This release contains information that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in those sections. Generally, we have identified such forward-looking statements by using the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “target,” “forecast,” “aim,” “should,” “will,” “may” and similar expressions or by using future dates in connection with any discussion of, among other things, operating performance, trends, events or developments that we expect or anticipate will occur in the future, statements relating to volume changes, share of sales and earnings per share changes, anticipated cost savings, potential capital and operational cash improvements, U. S. Steel’s ability to take ownership of Big River Steel as a wholly owned subsidiary, and statements expressing general views about future operating results. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements are not historical facts, but instead represent only the Company’s beliefs regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward looking statements. Management believes that these forward-looking statements are reasonable as of the time made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. The Company undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to the risks and uncertainties described in “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and those described from time to time in our future reports filed with the Securities and Exchange Commission. References to “we,” “us,” “our,” the “Company,” and “U. S. Steel,” refer to United States Steel Corporation and its consolidated subsidiaries.

UNITED STATES STEEL CORPORATION

NON-GAAP FINANCIAL MEASURES

RECONCILIATION OF ADJUSTED EBITDA GUIDANCE

     

 

(Dollars in millions)

 

 

 

 

Reconciliation to Projected Adjusted EBITDA Included in Guidance

4Q 2020

Projected net loss attributable to United States Steel Corporation included in guidance

 

$

(215)

Estimated income tax provision

 

 

10

Estimated net interest and other financial costs

 

 

80

Estimated depreciation, depletion and amortization

 

 

160

Projected EBITDA included in guidance

 

$

35

Estimated fourth quarter adjustments

 

 

20

Projected adjusted EBITDA included in guidance

 

$

55

     

UNITED STATES STEEL CORPORATION

NON-GAAP FINANCIAL MEASURES

RECONCILIATION OF ADJUSTED NET LOSS GUIDANCE

   

 

(Dollars in millions, except per share amounts)

   

Reconciliation to Projected Adjusted Net Loss Attributable to U. S. Steel Included in Guidance

 

4Q 2020

Projected net loss attributable to United States Steel Corporation included in guidance

 

$

(215)

Estimated fourth quarter adjustments

 

 

25

Projected adjusted net loss attributable to United States Steel Corporation included in guidance

 

$

(190)

Reconciliation to Projected Adjusted Diluted Net Loss Per Share Included in Guidance

 

4Q 2020

Projected diluted net loss per share included in guidance

$

(0.96)

Estimated fourth quarter adjustments

 

 

0.11

Projected adjusted diluted net loss per share included in guidance

 

$

(0.85)

 

Note: Excludes the impact of the Company’s quarterly adjustment related to the Big River Steel put and call options. See Notes 5 and 20 in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 for an explanation of the Big River Steel put and call options. This item will not impact adjusted EBITDA, adjusted net loss or adjusted diluted net loss per share. The guidance also excludes the discrete impact of intraperiod tax allocation primarily related to the annual remeasurement of our pension and other post-employment benefit plans. This item will not impact adjusted EBITDA.

Note Regarding Non-GAAP Financial Measures

We present adjusted net earnings (loss), adjusted net earnings (loss) per diluted share, earnings (loss) before interest, income taxes, depreciation and amortization (EBITDA) and adjusted EBITDA, which are non-GAAP measures, as additional measurements to enhance the understanding of our operating performance. We believe that EBITDA, considered along with net earnings (loss), is a relevant indicator of trends relating to our operating performance and provides management and investors with additional information for comparison of our operating results to the operating results of other companies.

Adjusted net earnings (loss), adjusted net earnings (loss) per diluted share and adjusted EBITDA are non-GAAP measures that exclude the financial effects of restructuring charges and other adjustments that are not part of the Company’s core operations. We present adjusted net earnings (loss), adjusted net earnings (loss) per diluted share and adjusted EBITDA to enhance the understanding of our ongoing operating performance and established trends affecting our core operations, by excluding the financial effects of restructuring charges and other adjustments that can obscure underlying trends. U. S. Steel’s management considers adjusted net earnings (loss), adjusted net earnings (loss) per diluted share and adjusted EBITDA as alternative measures of operating performance and not alternative measures of the Company’s liquidity. U. S. Steel’s management considers adjusted net earnings (loss), adjusted net earnings (loss) per diluted share and adjusted EBITDA useful to investors by facilitating a comparison of our operating performance to the operating performance of our competitors. Additionally, the presentation of adjusted net earnings (loss), adjusted net earnings (loss) per diluted share and adjusted EBITDA provides insight into management’s view and assessment of the Company’s ongoing operating performance, because management does not consider the adjusting items when evaluating the Company’s financial performance. Adjusted net earnings (loss), adjusted net earnings (loss) per diluted share and adjusted EBITDA should not be considered a substitute for net earnings (loss), earnings (loss) per diluted share or other financial measures as computed in accordance with U.S. GAAP and is not necessarily comparable to similarly titled measures used by other companies.

Founded in 1901, the United States Steel Corporation is a Fortune 250 company and leading integrated steel producer. With extensive iron ore production and an annual raw steelmaking capability of 23.6 million net tons, U. S. Steel produces high value-added steel products for the automotive, infrastructure, appliance, container, and energy industries. The company’s customer-centric “Best of Both” world competitive integrated and mini mill technology strategy is advancing a more secure, sustainable future for U. S. Steel and its stakeholders. With renewed emphasis on innovation and customer focus, the company produces cutting-edge products such as U. S. Steel’s proprietary XG3™ advanced high-strength steel. U. S. Steel is headquartered in Pittsburgh, Pennsylvania, with world-class operations across the United States and in Central Europe. For more information, please visit www.ussteel.com.

John Ambler

Vice President

Corporate Communications

T – (412) 433-2407

E – [email protected]

Kevin Lewis

Vice President

Investor Relations

T – (412) 433-6935

E – [email protected]

KEYWORDS: United States North America Pennsylvania

INDUSTRY KEYWORDS: Steel Manufacturing

MEDIA:

Logo
Logo